Transcriptomics and metabolomics analysis of the pathogenesis of a novel hyperlipidemia-susceptible rat strain
Experimental Animals · 2025
DOI: 10.1538/expanim.24-0080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Animals, 2025. Verfasst von Xiufeng Ai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Animal Experimental Research Center/Institute of Comparative Medicine, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangz…. Hauptthemen laut MEDLINE: Hyperlipidemias, Disease Models, Animal, Metabolomics, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Wistar-SD Hypercholesterolemia (WSHc) Rat is a novel hyperlipidemia-susceptible rat that we discovered and bred earlier, which can be used as an ideal animal model for the study of non-alcoholic fatty liver disease (NAFLD). However, its pathogenesis of hyperlipidemia and genetic and biological characteristics need to be further investigated. In the current study, WSHc rats were fed a high-fat diet (HFD) and standard chow (SC), with age-matched Wistar rats as the control group undergoing the same treatment, followed by serum lipid level measurement. It was found that HFD-fed WSHc rats developed dyslipidemia. Transcriptomic analysis was performed to detect genes associated with cholesterol metabolism in the liver, and 119 differentially expressed genes were discovered through bioinformatics analysis and molecular biology verification. Additionally, Srebf1 was identified as a HUB gene and Nr1d1 as an independent key gene using the protein-protein interaction network and one-cluster clustering analysis. The two genes had also been further validated in molecular biology experiments and were consistent with transcriptomic results. Serum lipid metabolomics analysis identified 7 lipid subclasses and 84 lipid molecules using UHPLC-Q-TOF/MS. There were 62 and 70 lipid molecules with significant differences in the metabolic profiles of serum lipid mediators in the WSHc+HFD group compared to the WSHc+SC and Wistar+HFD groups, respectively, and the differential metabolites were mainly produced via sphingolipid and glycerophospholipid metabolism. In sum, the hypercholesterolemia model can be established with WSHc rats after the HFD induction, and the pathogenesis involves the Srebf1 and Nr1d1 genes and the sphingolipid and glycerophospholipid metabolism pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Animal Experimental Research Center/Institute of Comparative Medicine, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, Zhejiang 310053, P.R. China.
- Key laboratory of silkworm and bee resource utilization and innovation of Zhejiang Province, College of Animal Sciences, Zhejiang University, 866 Yuhangtang Road, Xihu District, Hangzhou, Zhejiang 310058, P.R. China.
- Hangzhou Lifutai Biotechnology Co., LTD, 9 Juyuan Road, Binjiang District, Hangzhou, Zhejiang 310051, P.R. China.
- Department of Experimental Animals, Zhejiang Academy of Traditional Chinese Medicine, 132 Tianmushan Road, Xihu District, Hangzhou, Zhejiang 310007, P.R. China.
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Ai, X., Zhang, Q., Ma, Q., Fang, M., Zhu, K., Cai, Y., Yang, Q., & Zhang, L. (2025). Transcriptomics and metabolomics analysis of the pathogenesis of a novel hyperlipidemia-susceptible rat strain. Experimental Animals. https://doi.org/10.1538/expanim.24-0080
Vancouver
Ai X, Zhang Q, Ma Q, Fang M, Zhu K, Cai Y, et al. Transcriptomics and metabolomics analysis of the pathogenesis of a novel hyperlipidemia-susceptible rat strain. Experimental Animals. 2025. doi:10.1538/expanim.24-0080
BibTeX
@article{Ai2025,
author = {Ai, Xiufeng and Zhang, Qian and Ma, Quanxin and Fang, Mingsun and Zhu, Keyan and Cai, Yueqin and Yang, Qinqin and Zhang, Lizong},
title = {Transcriptomics and metabolomics analysis of the pathogenesis of a novel hyperlipidemia-susceptible rat strain},
journal = {Experimental Animals},
year = {2025},
doi = {10.1538/expanim.24-0080}
}
EUVIMED